Logo

The prevalence of Behçet’s disease in the north of Jordan: a hospital-based epidemiological survey

1, 2, 3, 4, 5, 6, 7

  1. Medical Department, Jordan’s Friends of Behçet’s Disease Patients Society, Amman, Jordan. wmadanat@orange.jo
  2. Department of Medicine, King Abdullah Hospital, Jordan University of Science and Technology, Irbid, Jordan.
  3. Department of Mathematics and Statistics, Jordan University of Science and Technology, Irbid, Jordan.
  4. Department of Medicine, King Abdullah Hospital, Jordan University of Science and Technology, Irbid, Jordan.
  5. Department of Medicine, King Abdullah Hospital, Jordan University of Science and Technology, Irbid, Jordan.
  6. Department of Medicine, King Abdullah Hospital, Jordan University of Science and Technology, Irbid, Jordan.
  7. Cerrahpaşa Hospital, University of Istanbul, Turkey.

CER10159 Submission on line
2017 Vol.35, N°6 ,Suppl.108 - PI 0051, PF 0054
Full Papers

Rheumatology Article

 

Abstract

OBJECTIVES:
To estimate the prevalence of Behçet’s disease (BD) in Jordan, with the additional aim of comparing this prevalence among hospital workers in other geographical areas.
METHODS:
In the first stage of our survey, 2,569 employees from 6 hospitals in north Jordan were interviewed using a screening questionnaire to identify individuals with recurrent oral ulcers (ROU), a previous diagnosis of BD (PDBD) and/or any major symptom related to BD. In the second stage, all individuals with ROU or PDBD identified at stage 1, were examined by 2 rheumatologists for the presence/confirmation of BD according to the International Study Group (ISG) criteria. Pathergy test was performed according to recommendations.
RESULTS:
ROU were present in 210 (8.2%) individuals. BD was confirmed in 10 employees with PDBD. Seven more BD patients were found. Mean age of 17 BD patients was 38.6±10.7 (range 26-65 y). M: F was 2.4:1. Pathergy test was positive in 8/17. A family history of ROU or BD was noted in 9 (52%) and 3 (25.0%), respectively, compared to 227 (8.9%) and 62 (2.6%) in the whole group, excluding the BD patients (p<0.001 and 0.008, respectively). The prevalence rate of BD in the north of Jordan was estimated as 66:10.000 (95% CI 34.8 to 97.5:10000).
CONCLUSIONS:
The results of this first ever survey indicated that the prevalence of BD in the north of Jordan is among the highest in the world. This prevalence can now be compared to hospital workers in other geographical areas.

PMID: 29224587 [PubMed]

Received: 07/12/2016 - Accepted : 14/02/2017 - In Press: 27/11/2017 - Published: 27/11/2017